Literature DB >> 6812676

Elimination of glyceryl trinitrate: effects of sex, age, species and route of administration.

C Ioannides, D V Parke, I W Taylor.   

Abstract

1 Orally administered glyceryl trinitrate to rats undergoes extensive first pass metabolism leading to low bioavailability. 2 Sex differences in the plasma elimination of glyceryl trinitrate were seen in the rat, the female exhibiting the longer plasma half-life. No sex differences in this respect were detected in the rabbit. 3 The plasma half-life of glyceryl trinitrate was longer and the volume of distribution larger, in older animals. 4 The plasma elimination of glyceryl trinitrate was different in various animal species. There was a good correlation between plasma half-life and animal bodyweight.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812676      PMCID: PMC2044638          DOI: 10.1111/j.1476-5381.1982.tb09272.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Glutathione S-transferase in the formation of cyanide from organic thiocyantes and as an organic nitrate reductase.

Authors:  W H Habig; J H Keen; W B Jakoby
Journal:  Biochem Biophys Res Commun       Date:  1975-05-19       Impact factor: 3.575

2.  Prophylactic therapy of angina pectoris with organic nitrates: relationship of drug efficacy and clinical experimental design.

Authors:  A A Stipe; G B Fink
Journal:  J Clin Pharmacol       Date:  1973-07       Impact factor: 3.126

Review 3.  Organic nitrate metabolism.

Authors:  P Needleman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1976       Impact factor: 13.820

4.  The metabolism of glyceryl trinitrate by liver and blood from different species.

Authors:  N H Lee
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

5.  Effect of sex and castration on hepatic and intestinal activity of drug-metabolizing enzymes.

Authors:  E Hietanen
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

6.  Clearance and metabolism of organic nitrates.

Authors:  E M Johnson; A B Harkey; D J Blehm; P Needleman
Journal:  J Pharmacol Exp Ther       Date:  1972-07       Impact factor: 4.030

7.  Organic nitrates: relationship between biotransformation and rational angina pectoris therapy.

Authors:  P Needleman; S Lang; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

8.  Tolerance to the vascular effects of glyceryl trinitrate.

Authors:  P Needleman
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

9.  Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.

Authors:  T Winsor; H J Berger
Journal:  Am Heart J       Date:  1975-11       Impact factor: 4.749

10.  Effect of development on the activity of microsomal drug-metabolizing enzymes in rat liver.

Authors:  T K Basu; J W Dickerson; D V Parke
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  3 in total

1.  The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.

Authors:  Michael A Malfatti; Heather A Enright; Nicholas A Be; Edward A Kuhn; Saphon Hok; M Windy McNerney; Victoria Lao; Tuan H Nguyen; Felice C Lightstone; Timothy S Carpenter; Brian J Bennion; Carlos A Valdez
Journal:  Chem Biol Interact       Date:  2017-09-21       Impact factor: 5.192

Review 2.  Nitrates in the elderly. Pharmacological considerations.

Authors:  J G Kelly; K O'Malley
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

3.  RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine.

Authors:  Sara Hougaard Pedersen; Lasse Maretty; Roshni Ramachandran; Jonas Andreas Sibbesen; Victor Yakimov; Rikke Elgaard-Christensen; Thomas Folkmann Hansen; Anders Krogh; Jes Olesen; Inger Jansen-Olesen
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.